Johnson & Johnson (JNJ) has agreed to buy Momenta Pharma (MNTA), a biotech focused on discovering and developing novel biologic therapeutics for rare …
The European Commission announced Thursday that it has concluded exploratory talks with US pharmaceutical company Johnson & Johnson to secure the initial purchase …
Johnson & Johnson (JNJ) initiated first-in-human safety trials of its COVID-19 vaccine candidate after a single dose in pre-clinical studies showed “robust protection”. …
The European Union is reportedly in talks to make advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna (MRNA), Sanofi (SNY) and …
Johnson & Johnson (JNJ) exceeded analysts’ profit and sales expectations in the second quarter and lifted its earnings guidance for the full year …
Johnson & Johnson’s (JNJ) bid to toss out a jury verdict in favor of women who blamed their ovarian cancer on its baby …
The European Commission is reportedly in advanced talks with Johnson & Johnson (JNJ) to purchase up-front doses of its COVID-19 vaccine candidate. According …
Johnson & Johnson (JNJ) said on Wednesday that it will start human trials of its COVID-19 vaccine as early as in the second …
Five companies have now been picked by the Trump administration as the most likely candidates to produce a coronavirus vaccine, The New York …
Johnson & Johnson (JNJ) has decided to permanently discontinue talc-based Johnson’s Baby Powder in both the US and Canada, citing declining demand and …
